Company Monitoring Page for Roche

latest headlines for company on cafepharma

Immunotherapies, biosimilars to dominate next week of earnings
Biopharma Dive
Tue, 04/24/18 - 10:50 pm
Tags:
AbbVie, AstraZeneca, Bristol-Myers Squibb, Celgene, Roche, Vertex Pharmaceuticals, Sanofi, earnings
FDA Fails to Approve Pfizer's Biosimilar of Roche's Herceptin
CP Wire
Mon, 04/23/18 - 09:28 am
Tags:
Pfizer, FDA, Roche, Herceptin, biosimilars
Mon, 04/23/18 - 09:20 am
Tags:
Pfizer, Herceptin, biosimilars, trastuzumab, Roche
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
CP Wire
Thu, 04/19/18 - 12:30 am
Tags:
Roche, cobas EGFR Mutation Test, Tagrisso, non-small cell lung cancer, AstraZeneca
Thu, 04/19/18 - 12:13 am
Tags:
Roche, Tagrisso, non-small cell lung cancer
Roche gets double dose of good Hemlibra news with FDA breakthrough, ICER backing
Fierce Pharma
Tue, 04/17/18 - 11:33 am
Tags:
Roche, Hemlibra, hemophilia, FDA, breakthrough status, ICER
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
Sun, 04/15/18 - 10:04 pm
Tags:
lung cancer, cancer, Merck, Roche, Bristol-Myers Squibb, AACR, non-small cell lung cancer
Roche halts enrollment in a PhII combo study of Tecentriq and Cotellic in wake of several patient deaths
Endpoints
Wed, 04/11/18 - 11:02 am
Tags:
Roche, Tecentriq, clinical trials, colon cancer, Exelixis, Cotellic
Incyte's Horrible News Derails a Promising Class of Cancer Drugs
Motley Fool
Fri, 04/6/18 - 07:43 pm
Tags:
Incyte, Merck, epacadostat, IDO inhibitors, Roche, NewLink Genetics
Roche Acquires MS Remyelination Program from Versant Ventures
CP Wire
Wed, 04/4/18 - 08:52 am
Tags:
Roche, MS, multiple sclerosis, remylination, M&A, Versant Ventures, Inception 5
Wed, 04/4/18 - 08:48 am
Tags:
Roche, Versant Ventures, multiple sclerosis
Under fire for 5 deaths of patients taking Hemlibra, Roche spills details
Fierce Pharma
Fri, 03/30/18 - 05:56 pm
Tags:
Hemlibra, Roche, hemophilia
Hemophilia groups warned of 5 deaths among patients taking Roche’s big new blockbuster Hemlibra
Endpoints
Tue, 03/27/18 - 10:13 pm
Tags:
hemophilia, Roche, Hemlibra
Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week
Fierce Pharma
Mon, 03/26/18 - 10:37 pm
Tags:
Roche, Avastin, Tecentriq, lung cancer
Roche's Tecentriq cocktail notches another lung cancer success
Yahoo/Reuters
Mon, 03/26/18 - 09:38 am
Tags:
Roche, Tecentriq, lung cancer, clinical trials
Amgen and Allergan Hopeful that Herceptin Biosimilar Approval Will Be Around the Corner
Xtalks
Mon, 03/26/18 - 09:36 am
Tags:
Amgen, Allergan, Herceptin, biosimilars, ABP 980, CHMP, EMA, Roche
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
Tags:
drug launches, Hemlibra, Roche, Biktarvy, Gilead Sciences, Ozempic, Novo Nordisk, Erleada, JNJ, Shingrix, GSK, Patisiran, Alnylam, Sanofi, Epidiolex, GW Pharma, Aimovig, Amgen, Novartis, lanadelumab, Shire, Elagolix, AbbVie, Steglatro, Pfizer, Merck, Sublocade, Indivior
Roche's Tecentriq triumphs in squamous lung cancer. Can it make its mark against Merck?
Fierce Pharma
Tue, 03/20/18 - 03:27 pm
Tags:
Roche, Tecentriq, squamous non-small cell lung cancer, Merck, Keytruda
With Novartis and Roche gunning to carve up Eylea franchise, Regeneron has another PhIII success story to tell
Endpoints
Mon, 03/19/18 - 11:44 am
Tags:
Novartis, Roche, Eylea, Regeneron
AbbVie blockbuster leads 2017 top drug sales; Roche cancer meds follow closely
S&P Global
Wed, 03/14/18 - 09:38 pm
Tags:
AbbVie, Roche, Humira, Rituxan, Herceptin, Avastin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.